<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for ZLCS</title>
    <link />
    <description>Headlines for Zalicus Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Zalicus Advancing Clinical Development of Z944, Its Novel, Oral, T-Type Calcium Channel Blocker, for</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/04/zalicus-advancing-clinical-development-of-z944-its/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 04 Jun 2013 07:50:24 GMT</pubDate>
    </item>
    <item>
      <title>Zalicus Announces Advancing Clinical Development of Z944</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/06/3645204/zalicus-announces-advancing-clinical-development-of-z944.aspx</link>
      <author>Benzinga</author>
      <pubDate>Tue, 04 Jun 2013 07:38:08 GMT</pubDate>
    </item>
    <item>
      <title>Zalicus to Present at the Jefferies 2013 Global Healthcare Conference</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/29/zalicus-to-present-at-the-jefferies-2013-global-he/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 29 May 2013 08:51:14 GMT</pubDate>
    </item>
    <item>
      <title>Zalicus Awaiting Data On Potential New Pain Medication</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1456311-zalicus-awaiting-data-on-potential-new-pain-medication.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 23 May 2013 08:19:00 GMT</pubDate>
    </item>
    <item>
      <title>Zalicus Presents Data on Novel, Oral, N- and T-Type Calcium Channel Blockers for the Treatment of Pa</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/10/zalicus-presents-data-on-novel-oral-n-and-t-type-c/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 10 May 2013 09:05:14 GMT</pubDate>
    </item>
    <item>
      <title>Zalicus Secures New $25 Million Funding Commitment from Lincoln Park Capital</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/08/zalicus-secures-new-25-million-funding-commitment-/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 08 May 2013 08:51:46 GMT</pubDate>
    </item>
    <item>
      <title>3 Promising Treatments for a Surprisingly Common Health Problem</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/03/3-promising-treatments-for-a-surprisingly-common-h/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 03 May 2013 19:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Watching Zalicus Like A Hawk</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1394551-watching-zalicus-like-a-hawk.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 02 May 2013 13:39:21 GMT</pubDate>
    </item>
    <item>
      <title>2 Biotechs Primed For Prosperity In 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1394101-2-biotechs-primed-for-prosperity-in-2013.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 02 May 2013 12:09:17 GMT</pubDate>
    </item>
    <item>
      <title>Zalicus Reports Financial Results for the First Quarter 2013</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/02/zalicus-reports-financial-results-for-the-first-qu/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 02 May 2013 08:01:34 GMT</pubDate>
    </item>
    <item>
      <title>Zalicus: Renewal Novartis Partnership Will Be Vital For 2013 Revenues</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1317051-zalicus-renewal-novartis-partnership-will-be-vital-for-2013-revenues.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 03 Apr 2013 07:25:06 GMT</pubDate>
    </item>
    <item>
      <title>Zalicus Granted Key Formulation Patent for Z160</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/02/zalicus-granted-key-formulation-patent-for-z160/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 02 Apr 2013 08:20:54 GMT</pubDate>
    </item>
    <item>
      <title>AcelRx Pharmaceutical's Potential Billion-Dollar Treatment Under The Radar</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1284291-acelrx-pharmaceutical-s-potential-billion-dollar-treatment-under-the-radar.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 19 Mar 2013 08:32:00 GMT</pubDate>
    </item>
    <item>
      <title>Zalicus Presents Data Demonstrating Advantages of State-Dependent Ion Channel Screening</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/19/zalicus-presents-data-demonstrating-advantages-of-/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 19 Mar 2013 08:21:35 GMT</pubDate>
    </item>
    <item>
      <title>A Study Of 3 Biotechs - A Story Of Hope, Potential And Partnerships</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1282591-a-study-of-3-biotechs-a-story-of-hope-potential-and-partnerships.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 18 Mar 2013 09:28:28 GMT</pubDate>
    </item>
    <item>
      <title>Why Zalicus' Stock Intrigues</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1255921-why-zalicus-stock-intrigues.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 07 Mar 2013 13:00:04 GMT</pubDate>
    </item>
    <item>
      <title>Oppenheimer Reiterates Outperform Rating, $2 PT on Zalicus Following 4Q12 Results</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3395302/oppenheimer-reiterates-outperform-rating-2-pt-on-zalicus.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 06 Mar 2013 12:56:13 GMT</pubDate>
    </item>
    <item>
      <title>Zalicus Reports Financial Results for the Fourth Quarter and Year End 2012</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/06/zalicus-reports-financial-results-for-the-fourth-q/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 06 Mar 2013 07:50:45 GMT</pubDate>
    </item>
    <item>
      <title>Speculative Biotech Stocks That Could Bounce 50% On Upcoming Catalysts</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1211421-speculative-biotech-stocks-that-could-bounce-50-on-upcoming-catalysts.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 21 Feb 2013 12:53:37 GMT</pubDate>
    </item>
    <item>
      <title>Zalicus Granted Composition-of-Matter Patent for Z944</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/20/zalicus-granted-composition-of-matter-patent-for-z/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 20 Feb 2013 08:20:53 GMT</pubDate>
    </item>
  </channel>
</rss>
